0000899243-23-007798.txt : 20230309
0000899243-23-007798.hdr.sgml : 20230309
20230309213223
ACCESSION NUMBER: 0000899243-23-007798
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180629
FILED AS OF DATE: 20230309
DATE AS OF CHANGE: 20230309
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SASSINE ANDY
CENTRAL INDEX KEY: 0001515322
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09341
FILM NUMBER: 23721453
MAIL ADDRESS:
STREET 1: 82 DEVONSHIRE STREET
CITY: BOSTON
STATE: MA
ZIP: 02109
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICAD INC
CENTRAL INDEX KEY: 0000749660
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 020377419
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
BUSINESS PHONE: 603-882-5200
MAIL ADDRESS:
STREET 1: 98 SPIT BROOK ROAD, SUITE 100
CITY: NASHUA
STATE: NH
ZIP: 03062
FORMER COMPANY:
FORMER CONFORMED NAME: HOWTEK INC
DATE OF NAME CHANGE: 19920703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-29
0
0000749660
ICAD INC
ICAD
0001515322
SASSINE ANDY
98 SPIT BROOK ROAD, SUITE 100
NASHUA
NH
03062
1
0
0
0
Director Stock Option (right to buy)
3.05
2018-06-29
4
D
0
6219
D
2023-06-29
Common Stock
6219
0
D
Director Stock Option (right to buy)
3.05
2023-03-07
4
A
0
6219
A
2028-06-29
Common Stock
6219
6219
D
Director Stock Option (right to buy)
2.91
2018-09-28
4
D
0
6517
D
2023-09-28
Common Stock
6517
0
D
Director Stock Option (right to buy)
2.91
2023-03-07
4
A
0
6517
A
2028-09-28
Common Stock
6517
6517
D
Director Stock Option (right to buy)
3.70
2018-12-31
4
D
0
9321
D
2023-12-31
Common Stock
9321
0
D
Director Stock Option (right to buy)
3.70
2023-03-07
4
A
0
9321
A
2028-12-31
Common Stock
9321
9321
D
The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on June 29, 2018 and is fully vested as of the date hereof.
The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on September 28, 2018 and is fully vested as of the date hereof.
The two reported transactions involved an amendment to an outstanding option, resulting in the cancellation of the "old" option and the grant of a replacement option. The option was originally granted on December 31, 2018 and is fully vested as of the date hereof.
On March 7, 2023, the Board of Directors of the Issuer agreed to a modification of the exercise period for certain outstanding stock options granted to the Director in 2018 that would otherwise expire in November 2023 such that they now have an aggregate exercise period of ten years. No other modification was made to the option.
/s/ Andy Sassine
2023-03-09